okt 18, 2018: 6 p.m. - 6:30 p.m.
California West

The BIO SPARK Showcase aims to provide an excellent opportunity for academic researchers in the SPARK network to showcase drug development programs that are ready for partnering or venture funding.

The BIO Investor Forum is historically well attended by the venture arms and business development units of major pharmaceutical companies, smaller specialty pharma/biotech companies looking to add to their pipelines, start-ups, and many early stage venture capital firms, making it the ideal setting for early stage assets from the university setting. Academics interested in partnering will present their programs and also have one-on-one discussions with interested parties.

Welcome from SPARK Translational Research Program, Stanford Medicine
  • Kevin Grimes, MD, Co-Director
Stanford University--Bert Pharma
New Small Molecule Anesthetics for high risk infants/ elderly
Ed Bertaccini
SPARK Colorado- Aurora Oncology
Intravesical DAB389EGF for the treatment of bladder cancer
Professor Michael Glode
Stanford University
Novel Treatment for Kidney Cancer
Arvin Gouw/ Dean Felsher
SPARK Colorado- ThromboTherapeutics Inc
tPA-Challenged Viscoelastometric Hemostatic Assay for Early Identification of Life-Threatening Coagulopathy in Trauma
Michael Chapman, Resident at Department of Radiology